TG Therapeutics
TGTX
TGTX
350 hedge funds and large institutions have $3.58B invested in TG Therapeutics in 2025 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 103 increasing their positions, 134 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
1% less funds holding
Funds holding: 354 → 350 (-4)
1.62% less ownership
Funds ownership: 64.02% → 62.4% (-1.6%)
23% less repeat investments, than reductions
Existing positions increased: 103 | Existing positions reduced: 134
Holders
350
Holding in Top 10
5
Calls
$80.5M
Puts
$82M
Top Buyers
| 1 | +$57.8M | |
| 2 | +$57.5M | |
| 3 | +$31.4M | |
| 4 |
Squarepoint
New York
|
+$18.2M |
| 5 |
State Street
Boston,
Massachusetts
|
+$17.4M |
Top Sellers
| 1 | -$42.2M | |
| 2 | -$30.4M | |
| 3 | -$29.1M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$21.4M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$21.3M |
